Cellectis falls as Citizens downgrades on pivot to genetic medicines
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Democrats hammered Treasury Secretary Bessent over rising borrowing costs at a House hearing
The 10-year Treasury note hit 5% Tuesday as Democrats challenged Bessent's defense of the administration's economic record ahead of midterms
NDB $1bn loan, prescribed benefits reform, and automotive masterplan
We cover market updates with WealthStrat, unpack Attacq’s results, examine the NDB’s municipal infrastructure loan, explore medical aid benefit reforms, assess automotive industry competitiveness, and…
I Like SpaceX, But I'm Not Buying the Stock for One Simple Reason
SpaceX could become one of the greatest companies of our time. But owning the stock today is not for the faint-hearted.
CFTC Probes Voluntary Carbon Credits as Market Scrutiny Grows
The US derivatives regulator is conducting a broad probe into the voluntary carbon credit market, an industry that boomed when corporations started pledging to reduce their emissions but has shrunk…
Tech stocks under pressure
Victoria Reuvers of WealthStrat discusses higher oil prices, rising bond yields and a stronger US dollar, as well as weaker US markets amid AI concerns.
22 Prominent Investors Hold Netflix Stock, With 14 Increasing Their Stakes Recently -- Including Bill Ackman's Pershing Square. Should You Follow Their Example?
Bill Ackman closed his Netflix position in 2022. A 50% drawdown and a collapsed multiple brought him back.